GHCM
ARNA

Glen Harbor Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Glen Harbor Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-336
Closed -$15K – 1342
2019
Q1 		$15K Hold
336
– – ﹤0.01% 1287
2018
Q4 		$13K Buy
+336
New +$13.2K ﹤0.01% 1258

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Glen Harbor Capital Management's ARNA Position: Q2 2019 in Review

Glen Harbor Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 336 shares — an estimated $15K sold.

Glen Harbor Capital Management first reported a position in ARNA in Q4 2018 and held it in 2 quarters. The position peaked at $15K in Q1 2019. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • Glen Harbor Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 336 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $15K.
  • Glen Harbor Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 2 quarters.
  • Glen Harbor Capital Management's Arena Pharmaceuticals Inc position peaked at $15K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.